Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Nature of the Business - Narrative (Details)

v3.22.2
Nature of the Business - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]            
PCR testing, amount recorded, COVID-19     $ 6,100,000 $ 0 $ 6,061,000  
PCR testing, write-offs, COVID-19     5,300,000      
PCR testing, general and administrative expenses, COVID-19 $ 0 $ 0 $ 800,000 0    
COVID-19, deferred social security payroll tax $ 3,000,000     $ 3,000,000   $ 3,000,000